Journal article
Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory
Mayo Clinic proceedings, Vol.98(5), pp.662-675
05/2023
DOI: 10.1016/j.mayocp.2022.12.024
PMCID: PMC9874044
PMID: 37137641
Abstract
Objective
To explore trends in blood pressure (BP) control before and during the COVID-19 pandemic.
Patients and Methods
Health systems participating in the National Patient-Centered Clinical Research Network (PCORnet) Blood Pressure Control Laboratory Surveillance System responded to data queries, producing 9 BP control metrics. Averages of the BP control metrics (weighted by numbers of observations in each health system) were calculated and compared between two 1-year measurement periods (January 1, 2019, through December 31, 2019, and January 1, 2020, through December 31, 2020).
Results
Among 1,770,547 hypertensive persons in 2019, BP control to <140/<90 mm Hg varied across 24 health systems (range, 46%-74%). Reduced BP control occurred in most health systems with onset of the COVID-19 pandemic; the weighted average BP control was 60.5% in 2019 and 53.3% in 2020. Reductions were also evident for BP control to <130/<80 mm Hg (29.9% in 2019 and 25.4% in 2020) and improvement in BP (reduction of 10 mm Hg in systolic BP or achievement of systolic BP <140 mm Hg; 29.7% in 2019 and 23.8% in 2020). Two BP control process metrics exhibited pandemic-associated disruption: repeat visit in 4 weeks after a visit with uncontrolled hypertension (36.7% in 2019 and 31.7% in 2020) and prescription of fixed-dose combination medications among those with 2 or more drug classes (24.6% in 2019 and 21.5% in 2020).
Conclusion
BP control decreased substantially during the COVID-19 pandemic, with a corresponding reduction in follow-up health care visits among persons with uncontrolled hypertension. It is unclear whether the observed decline in BP control during the pandemic will contribute to future cardiovascular events.
Details
- Title: Subtitle
- Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory
- Creators
- Alanna M. Chamberlain - Mayo Clinic in FloridaElizabeth A. Chrischilles - University of IowaRhonda M. Cooper-DeHoff - Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainesville, FLValy Fontil - University of California, San FranciscoEster Kim Nilles - Duke UniversityKathryn M. Shaw - Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FLMyra Smith - Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FLFeng Lin - University of California, San FranciscoEric Vittinghoff - University of California, San FranciscoCarlos Maeztu - Citizen Scientist, Department of Health Outcomes and Biomedical Informatics, University of Florida, Gainesville, FLJonathan V. Todd - OchinThomas Carton - Louisiana Public Health InstituteEmily C. O’Brien - Duke UniversityMadelaine Faulkner Modrow - University of California, San FranciscoGregory Wozniak - American Medical Association, Chicago, ILMichael Rakotz - American Medical Association, Chicago, ILEduardo Sanchez - American Heart Association, Dallas, TXSteven M. Smith - Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FLTamar S. Polonsky - University of ChicagoMei Liu - University of Kansas Medical CenterFaraz S. Ahmad - Northwestern UniversityJames C. McClay - University of Nebraska Medical CenterJeffrey J. VanWormer - Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, WIBradley W. Taylor - Medical College of WisconsinShenghui Wu - Appalachian State UniversityAnthony J. Viera - Duke UniversityDaniel E. Ford - Johns Hopkins Institute for Clinical and Translational Research, Baltimore, MDWenke Hwang - Pennsylvania State UniversityKirk U. Knowlton - Intermountain HealthcareMark J. Pletcher - University of California, San Francisco
- Resource Type
- Journal article
- Publication Details
- Mayo Clinic proceedings, Vol.98(5), pp.662-675
- DOI
- 10.1016/j.mayocp.2022.12.024
- PMID
- 37137641
- PMCID
- PMC9874044
- NLM abbreviation
- Mayo Clin Proc
- ISSN
- 0025-6196
- eISSN
- 1942-5546
- Publisher
- Mayo Foundation for Medical Education and Research. Published by Elsevier Inc
- Grant note
- DOI: 10.13039/100000968, name: American Heart Association; DOI: 10.13039/100006093, name: Patient-Centered Outcomes Research Institute, award: PaCR-2017C2-8153; DOI: 10.13039/100009457, name: American Medical Association, award: K23HL136899
- Language
- English
- Electronic publication date
- 01/25/2023
- Date published
- 05/2023
- Academic Unit
- Pharmacy; Epidemiology
- Record Identifier
- 9984363656202771
Metrics
16 Record Views